1,268
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Improving Concordance in Environmental Epidemiology: A Three-Part Proposal

, , &

REFERENCES

  • Alberts, B., M. W. Kirschner, S. Tilghman, S., and H. Varmus. 2014. Rescuing US biomedical research from its systemic flaws. Proceedings of the National Academy of Sciences USA 111: 5773–5777.
  • Altman, D. G. 1994. The scandal of poor medical research. British Medical Journal 308: 283–284.
  • Ambrosone, C. B., and F. F. Kadlubar. 1997. Toward an integrated approach to molecular epidemiology. American Journal of Epidemiology 146: 912–918.
  • Bellinger, D. C. 2009. Interpreting epidemiologic studies of developmental neurotoxicity: Conceptual and analytic issues. Neurotoxicology and Teratology 31: 267–274.
  • Bracken, M. B. 2011. Preregistration of epidemiology protocols: A commentary in support. Epidemiology 22:135–137.
  • Burns, C. J., L. J. McIntosh, P. J. Mink, A, M. Jurek, and A. A. Li. 2013. Pesticide exposure and neurodevelopmental outcomes: Review of the epidemiologic and animal studies. Journal of Toxicology and Environmental Health B 16:127–283.
  • Chalmers, I. 1993. The Cochrane Collaboration: Preparing, maintaining, and disseminating systematic reviews of the effects of health care. Annals of the New York Academy of Science 703: 156–165.
  • Chalmers, I., and P. Glasziou. 2009. Avoidable waste in the production and reporting of research evidence. Lancet 374: 86–89.
  • Chalmers, I., M. B. Bracken, B. Djulbegovic, S. Garattini, J. Grant, A. M. Gülmezoglu, D. W. Howells, J. P. Ioannidis, and S. Oliver. 2014. How to increase value and reduce waste when research priorities are set. Lancet 383: 156–165.
  • Corsini, E., M. Sokooti, C. L. Galli, A. Moretto, and C. Colosio. 2013. Pesticide induced immunotoxicity in humans: A comprehensive review of the existing evidence. Toxicology 307: 123–135.
  • De Angelis, C., J. M. Drazen, F. A. Frizelle, C. Haug, J. Hoey, R. Horton, S. Kotzin, C. Laine, A. Marusic, A. J. Overbeke, T. V. Schroeder, H. C. Sox, and M. B. Van Der Weyden, International Committee of Medical Journal Editors. 2004. Clinical trial registration: A statement from the International Committee of Medical Journal Editors. Canadian Medical Association Journal 171: 606–607.
  • Editors. 2010. The registration of observational studies—When metaphors go bad. Epidemiology 21: 607–609.
  • Feliciano-Alfonso, J. E., C. O. Mendivil, I. D. Ariza, and C. E. Pérez. 2010. Cardiovascular risk factors and metabolic syndrome in a population of young students from the National University of Colombia. Revista da Associação Médica Brasileira 56: 293–298.
  • Fortier, I., D. Doiron, P. Burton, and P. Raina. 2011. Invited commentary: Consolidating data harmonization—How to obtain quality and applicability? American Journal of Epidemiology 174: 261–264.
  • Gallagher, C. M., and J. R. Meliker. 2010. Blood and urine cadmium, blood pressure, and hypertension: A systematic review and meta-analysis. Environmental Health Perspectives 118: 1676–1684.
  • Gascon, M., E. Morales, J. Sunyer, and M. Vrijheid. 2013. Effects of persistent organic pollutants on the developing respiratory and immune systems: A systematic review. Environment International 52: 51–65.
  • Glasziou, P., D. G. Altman, P. Bossuyt, I. Boutron, M. Clarke, S. Julious, S. Michie, D. Moher, and E. Wager. 2014. Reducing waste from incomplete or unusable reports of biomedical research. Lancet 383: 267–276.
  • González-Alzaga, B., M. Lacasaña, C. Aguilar-Garduño, M. Rodríguez-Barranco, F. Ballester, M. Rebagliato, and A. F. Hernández. 2013. A systematic review of neurodevelopmental effects of prenatal and postnatal organophosphate pesticide exposure. Toxicology Letters 230: 104–121.
  • Goodman, M., K. Squibb, E. Youngstrom, L. G. Anthony, L. Kenworthy, P. H. Lipkin, D. R. Mattison, and J. S. LaKind. 2010. Using systematic reviews and meta-analyses to support regulatory decision making for neurotoxicants: Lessons learned from a case study of PCBs. Environmental Health Perspectives 118: 727–734.
  • Goodman, M., R. M. Bostick, O. Kucuk, and D. P. Jones. 2011. Clinical trials of antioxidants as cancer prevention agents: Past, present, and future. Free Radical Biology & Medicine 51: 1068–1084.
  • Goodman, M., J. S. LaKind, and D. R. Mattison. 2014. Do phthalates act as obesogens in humans? A systematic review of the epidemiological literature. Critical Reviews in Toxicology 44: 151–175.
  • Haagsma, J. A., S. Polinder, C. E. Stein, and A. H. Havelaar. 2013. Systematic review of foodborne burden of disease studies: Quality assessment of data and methodology. International Journal of Food Microbiology 166: 34–47.
  • Harris, J. R., P. Burton, B. M. Knoppers, K. Lindpaintner, M. Bledsoe, A. J. Brookes, I. Budin-Ljøsne, R. Chisholm, D. Cox, M. Deschênes, I. Fortier, P. Hainaut, R. Hewitt, J. Kaye, J. E. Litton, A. Metspalu, B. Ollier, L. J. Palmer, A. Palotie, M. Pasterk, M. Perola, P. H. Riegman, G. J. van Ommen, M. Yuille, and K. Zatloukal. 2012. Toward a roadmap in global biobanking for health. European Journal of Human Genetics 20: 1105–1111.
  • Higgins, J. P. T., and S. Green, eds. 2008. Cochrane handbook for systematic reviews of interventions: Cochrane book series. The Cochrane Collaboration. Updated March 2011. http://handbook.cochrane.org (accessed August 13, 2014).
  • International Clinical Trials Registry Platform. 2014. Trial registration. World Health Organization. http://www.who.int/ictrp/trial_reg/en (accessed February 20, 2015).
  • Ioannidis, J. P., S. Greenland, M. A. Hlatky, M. J. Khoury, M. R. Macleod, D. Moher, K. F. Schulz, and R. Tibshirani. 2014. Increasing value and reducing waste in research design, conduct, and analysis. Lancet 383: 166–175.
  • Koyashiki, G. A., M. M. Paoliello, and P. B. Tchounwou. 2010. Lead levels in human milk and children’s health risk: a systematic review. Reviews on Environmental Health 25: 243–253.
  • Krimsky, S. 2005. The weight of scientific evidence in policy and law. American Journal of Public Health 95: S129–S136.
  • LaKind, J. S., M. Goodman, and D. R. Mattison. 2014a. Bisphenol A and indicators of obesity, glucose metabolism/type 2 diabetes and cardiovascular disease: A systematic review of epidemiologic research. Critical Reviews in Toxicology 44: 121–150.
  • LaKind, J. S., J. R. Sobus, M. Goodman, D. B. Barr, P. Fürst, R. J. Albertini, T. E. Arbuckle, G. Schoeters, Y. M. Tan, J. Teeguarden, R. Tornero-Velez, and C. P. Weisel. 2014b. A proposal for assessing study quality: Biomonitoring, Environmental Epidemiology, and Short-Lived Chemicals (BEES-C) Instrument. Environment International 73: 195–207.
  • Lash, T. L. 2010. Preregistration of study protocols is unlikely to improve the yield from our science, but other strategies might. Epidemiology 21:612–613.
  • Li, A. A., K. A. Lowe, L. J. McIntosh, and P. J. Mink. 2012. Evaluation of epidemiology and animal data for risk assessment: Chlorpyrifos developmental neurobehavioral outcomes. Journal of Toxicology and Environmental Health B 15:109–184.
  • Macleod, M. R., S. Michie, I. Roberts, U. Dirnagl, I. Chalmers, J. P. Ioannidis, R. Al-Shahi Salman, A. W. Chan, and P. Glasziou. 2014. Biomedical research: Increasing value, reducing waste. Lancet 383:101–104.
  • Makris, S. L., H. M. Solomon, R. Clark, K. Shiota, S. Barbellion, J. Buschmann, M. Ema, M. Fujiwara, K. Grote, K. P. Hazelden, K. W. Hew, M. Horimoto, Y. Ooshima, M. Parkinson, and L. D. Wise. 2009. Terminology of developmental abnormalities in common laboratory mammals (version 2). Reproductive Toxicology 28: 371–434.
  • Manchikanti, L., R. M. Benyamin, S. Helm, and J. A. Hirsch. 2009. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 3: Systematic reviews and meta-analyses of randomized trials. Pain Physician 12: 35–72.
  • Maull, E. A., H. Ahsan, J. Edwards, M. P. Longnecker, A. Navas-Acien, J. Pi, E. K. Silbergeld, M. Styblo, C. H. Tseng, K. A. Thayer, and D. Loomis. 2012. Evaluation of the association between arsenic and diabetes: A National Toxicology Program workshop review. Environmental Health Perspectives 120: 1658–1670.
  • McGwin, G., J. Lienert, and J. I. Kennedy. 2010. Formaldehyde exposure and asthma in children: A systematic review. Environmental Health Perspectives 118: 313–317.
  • Moher, D. 1998. CONSORT: An evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials. Journal of the American Medical Association 279: 1489–1491.
  • Moher, D., A. Liberati, J. Tetzlaff, D. G. Altman, The PRISMA Group. 2009. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine 6: e1000097.
  • Moher, D., K. F. Schulz, I. Simera, and D. G. Altman. 2010. Guidance for developers of health research reporting guidelines. PLoS Medicine 7: e1000217.
  • Montori, V. M., and G. H. Guyatt. 2008. Progress in evidence-based medicine. Journal of the American Medical Association 300: 1814–1816.
  • Olsen, G. W., J. L. Butenhoff, and L. R. Zobel. 2009. Perfluoroalkyl chemicals and human fetal development: An epidemiologic review with clinical and toxicological perspectives. Reproductive Toxicology 27: 212–230.
  • Pearce, N. 2011. Registration of protocols for observational research is unnecessary and would do more harm than good. Occupational and Environmental Medicine 68: 86–88.
  • Pigeot, I., G. Barba, C. Chadjigeorgiou, S. de Henauw, Y. Kourides, L. Lissner, S. Marild, H. Pohlabeln, P. Russo, M. Tornaritis, T. Veidebaum, N. Wawro, and A. Siani. 2009. Prevalence and determinants of childhood overweight and obesity in European countries: Pooled analysis of the existing surveys within the IDEFICS Consortium. International Journal of Obesity (London) 33: 1103–1110.
  • Pleil, J. D., J. R. Sobus, M. A. Stiegel, D. Hu, K. D. Oliver, C. Olenick, M. Strynar, M. Clark, M., M. C. Madden, and W. E. Funk, W.E. 2014. Estimating common parameters of lognormally distributed environmental and biomonitoring data: Harmonizing disparate statistics from publications. Journal of Toxicology and Environmental Health B 17: 341–368.
  • PLoS Medicine Editors. 2011. Best practice in systematic reviews: The importance of protocols and registration. PLoS Medicine 8: e1001009.
  • PLOS Medicine Editors. 2014. Observational studies: Getting clear about transparency. PLoS Medicine 11: e1001711.
  • Poole, C. 2010. A vision of accessible epidemiology. Epidemiology 21: 616–618.
  • Rahmioglu, N., A. Fassbender, A. F. Vitonis, S. S. Tworoger, L. Hummelshoj, T. M. D’Hooghe, G. D. Adamson, L. C. Giudice, C. M. Becker, K. T. Zondervan, S. A. Missmer; WERF EPHect Working Group. 2014. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research. Fertility & Sterility 102: 1233–1243.
  • Rooney, A. A., A. L. Boyles, M. S. Wolfe, J. R. Bucher, and K. A. Thayer. 2014. Systematic review and evidence integration for literature-based environmental health science assessments. Environmental Health Perspectives 122: 711–718.
  • Rosenbaum, S. E., C. Glenton, and J. Cracknell. 2008. User experiences of evidence-based online resources for health professionals: User testing of The Cochrane Library. BMC Medical Informatics and Decision Making 8: 34.
  • Rushton, L. 2011. Should protocols for observational research be registered? Occupational and Environmental Medicine 68: 84–86.
  • Rushton, L., and D. Betts. 2000. Collection of data for occupational epidemiologic research—Results from a survey of European industry. Scandinavian Journal of Work, Environment & Health 26: 317–321.
  • Sackett, D. L., W. C. Rosenberg, J. A. Muir Gray, R. B. Haynes, and W. S. Richardson. 1996. Evidence based medicine: What it is and what it isn’t. British Medical Journal 312: 71–72.
  • Samet, J. M. 2010. To register or not to register. Epidemiology 21: 610–611.
  • Sankaranarayanan, R., E. Demaret, N. Becker, and J. Wahrendorf. 1999. Directory of on-going research in cancer prevention. International Journal of Cancer 83: 706–707.
  • Schoeman, K., J. R. Bend, J. Hill, K. Nash, and G. Koren. 2009. Defining a lowest observable adverse effect hair concentrations of mercury for neurodevelopmental effects of prenatal methylmercury exposure through maternal fish consumption: A systematic review. Therapeutic Drug Monitoring 31: 670–682.
  • Simera, I., D. Moher, A. Hirst, J. Hoey, K. F. Schulz, and D. G. Altman. 2010. Transparent and accurate reporting increases reliability, utility, and impact of your research: Reporting guidelines and the EQUATOR network. BMC Medicine 8: 24.
  • Takkouche, B., and G. Norman. 2010. Meta-analysis protocol registration: sed quis custodiet ipsos custodes? [but who will guard the guardians?]. Epidemiology 21: 614–615.
  • Tanjong-Ghogomu, E., P. Tugwell, and V. Welch. 2009. Evidence-based medicine and the Cochrane Collaboration. Bulletin of the NYU Hospital for Joint Diseases 67: 198–205.
  • Thayer, K. A., M. S. Wolfe, A. A. Rooney, A. L. Boyles, J. R. Bucher, and L. S. Birnbaum. 2014. Intersection of systematic review methodology with the NIH reproducibility initiative. Environmental Health Perspectives 122: A176–A177.
  • Timmermans, S., and A. Mauck. 2005. The promises and pitfalls of evidence-based medicine. Health Affairs 24: 18–28.
  • U.S. Environmental Protection Agency. 1996. Proposed guidelines for carcinogen risk assessment. Federal Register 61(79): 17960–18011.
  • U.S. Environmental Protection Agency. 2013. SAB advice on approaches to derive a maximum contaminant level goal for perchlorate. EPA-SAB-13-004. http://yosemite.epa.gov/sab/sabproduct.nsf/d21b76bff879fa0a8525735a00766807/d3bb75d4297ca4698525794300522ace!OpenDocument (accessed May 5, 2014).
  • Vandenbroucke, J. P. 2010. Preregistration of epidemiologic studies: An ill-founded mix of ideas. Epidemiology 21: 619–620.
  • von Elm, E., D. G. Altman, M. Egger, S. J. Pocock, P. C. Gøtzsche, J. P. Vandenbroucke; STROBE Initiative. 2007. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Epidemiology 18: 800–804.
  • Vrijheid, M., M. Casas, A. Bergström, A. Carmichael, S. Cordier, M. Eggesbø, E. Eller, M. P. Fantini, M. F. Fernández, A. Fernández-Somoano, U. Gehring, R. Grazuleviciene, C. Hohmann, A. M. Karvonen, T. Keil, M. Kogevinas, G. Koppen, U. Krämer, C. E. Kuehni, P. Magnus, R. Majewska, A. M. Andersen, E. Patelarou, M. S. Petersen, F. H. Pierik, K. Polanska, D. Porta, L. Richiardi, A. C. Santos, R. Slama, R. J. Sram, C. Thijs, C. Tischer, G. Toft, T. Trnovec, S. Vandentorren, T. G. Vrijkotte, M. Wilhelm, J. Wright, and M. Nieuwenhuijsen. 2012. European birth cohorts for environmental health research. Environmental Health Perspectives 120: 29–37.
  • Williams, R. J., T. Tse, W. R. Harlan, and D. A. Zarin. 2010. Registration of observational studies: Is it time? Canadian Medical Association Journal 182:1638–1642.
  • Woodruff, T. J., and P. Sutton. 2014. The Navigation Guide systematic review methodology: A rigorous and transparent method for translating environmental health science into better health outcomes. Environmental Health Perspectives 122: 1007–1014.
  • Youngstrom, E., L. Kenworthy, P. H. Lipkin, M. Goodman, K. Squibb, D. R. Mattison, L. G. Anthony, S. L. Makris, A. S. Bale, K. C. Raffaele, and J. S. LaKind. 2011. A proposal to facilitate weight-of-evidence assessments: Harmonization of Neurodevelopmental Environmental Epidemiology Studies (HONEES). Neurotoxicology and Teratology 33: 354–359.
  • Zielhuis, R. L., P. C. Noordam, C. L. Maas, J. J. Kolk, and H. P. Illing. 1991. Harmonization of criteria documents for standard setting in occupational health: A report of a workshop. Regulatory Toxicology and Pharmacology 13: 241–262.